Masakazu Toi

TL;DR: The newly developed PAI system prototype not only enhances the PA image resolution but also acquires ultrasonic B-mode images at continuous positions in the same coordinate axes, and the pulse-to-pulse alternating laser irradiation shortens the measurement time difference between two wavelengths.

TL;DR: The most clinically relevant data from breast cancer treatment clinical trials are summarized and safety and efficacy of common antiangiogenic therapies as well as biological predictive markers are discussed.

TL;DR: This assay provides a useful tool for the investigations of the expression levels of VEGFR‐3 in physiological and pathological processes, particular in cancer and in lymphangiogenesis‐related disease.

TL;DR: Racial differences in acute toxicity were noted in women with breast cancer who were treated with FEC 100 chemotherapy, suggesting that extrapolating toxicities from chemotherapy across ethnicities is not possible and emphasising the need to validate safety of chemotherapeutic regimens in patients of different ethnicities by enhancing the participation of minorities in clinical trials.

TL;DR: Both dedicated breast PET scanners are clinically feasible and yield reasonably high sensitivity, and more detailed information was obtained with these scanners than with the conventional scanner.